366 related articles for article (PubMed ID: 15824107)
1. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
3. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
5. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018
[TBL] [Abstract][Full Text] [Related]
9. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
[TBL] [Abstract][Full Text] [Related]
13. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
14. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.
Kondraganti S; Gondi CS; McCutcheon I; Dinh DH; Gujrati M; Rao JS; Olivero WC
Int J Oncol; 2006 Jun; 28(6):1353-60. PubMed ID: 16685436
[TBL] [Abstract][Full Text] [Related]
16. Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
Nalabothula N; Lakka SS; Dinh DH; Gujrati M; Olivero WC; Rao JS
Int J Oncol; 2007 Mar; 30(3):669-78. PubMed ID: 17273768
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Lakka SS; Jasti SL; Gondi C; Boyd D; Chandrasekar N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2002 Aug; 21(36):5601-8. PubMed ID: 12165859
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
[TBL] [Abstract][Full Text] [Related]
20. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
